Clinical practice guidelines for therapeutic drug monitoring of vancomycin in the framework of model-informed precision dosing: a consensus review by the Japanese …
K Matsumoto, K Oda, K Shoji, Y Hanai, Y Takahashi… - Pharmaceutics, 2022 - mdpi.com
Background: To promote model-informed precision dosing (MIPD) for vancomycin (VCM),
we developed statements for therapeutic drug monitoring (TDM). Methods: Ten clinical …
we developed statements for therapeutic drug monitoring (TDM). Methods: Ten clinical …
[PDF][PDF] The use of vancomycin with its therapeutic and adverse effects: a review.
FR Bruniera, FM Ferreira, LRM Saviolli… - European Review for …, 2015 - europeanreview.org
RESULTS: The main adverse effects of vancomycin are: hypotension, phlebitis,
nephrotoxicity, ototoxicity, hypersensitivity reactions, red man syndrome, neutropenia, chills …
nephrotoxicity, ototoxicity, hypersensitivity reactions, red man syndrome, neutropenia, chills …
Are vancomycin trough concentrations adequate for optimal dosing?
MN Neely, G Youn, B Jones, RW Jelliffe… - Antimicrobial agents …, 2014 - Am Soc Microbiol
The current vancomycin therapeutic guidelines recommend the use of only trough
concentrations to manage the dosing of adults with Staphylococcus aureus infections. Both …
concentrations to manage the dosing of adults with Staphylococcus aureus infections. Both …
Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of …
K Matsumoto, Y Takesue, N Ohmagari… - Journal of Infection and …, 2013 - Springer
Methods Clinical practice guidelines for TDM of VCM were reviewed by a practice guideline
committee that consisted of 18 experts in TDM convened from the JSC and the JSTDM. The …
committee that consisted of 18 experts in TDM convened from the JSC and the JSTDM. The …
Association between vancomycin trough concentration and area under the concentration-time curve in neonates
A Frymoyer, AL Hersh, MH El-Komy… - Antimicrobial agents …, 2014 - Am Soc Microbiol
National treatment guidelines for invasive methicillin-resistant Staphylococcus aureus
(MRSA) infections recommend targeting a vancomycin 24-h area under the concentration …
(MRSA) infections recommend targeting a vancomycin 24-h area under the concentration …
Making the change to area under the curve–based vancomycin dosing
Vancomycin, a glycopeptide antimicrobial, is commonly employed for empirical and
definitive treatment of infections due to resistant gram-positive pathogens, notably methicillin …
definitive treatment of infections due to resistant gram-positive pathogens, notably methicillin …
The dosing and monitoring of vancomycin: what is the best way forward?
We have evaluated the literature to review optimal dosing and monitoring of intravenous
vancomycin in adults, in response to evolving understanding of targets associated with …
vancomycin in adults, in response to evolving understanding of targets associated with …
Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond
There has been a welcome increase in the number of agents available for the treatment of
methicillin-resistant Staphylococcus aureus (MRSA). Vancomycin remains an acceptable …
methicillin-resistant Staphylococcus aureus (MRSA). Vancomycin remains an acceptable …
Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy
TW Felton, JA Roberts, TP Lodise… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Piperacillin-tazobactam is frequently used for empirical and targeted therapy of infections in
critically ill patients. Considerable pharmacokinetic (PK) variability is observed in critically ill …
critically ill patients. Considerable pharmacokinetic (PK) variability is observed in critically ill …
Pharmacokinetics/pharmacodynamics of β-lactams and therapeutic drug monitoring: from theory to practical issues in the intensive care unit
P Williams, MO Cotta, JA Roberts - Seminars in Respiratory and …, 2019 - thieme-connect.com
Despite therapeutic advances over recent decades, the mortality rate for sepsis and septic
shock is still approximately 25% worldwide. Early administration of appropriate intravenous …
shock is still approximately 25% worldwide. Early administration of appropriate intravenous …